SU583755A3 - Method of preparing heterogeneous ring compounds or salts thereof - Google Patents
Method of preparing heterogeneous ring compounds or salts thereofInfo
- Publication number
- SU583755A3 SU583755A3 SU7502145931A SU2145931A SU583755A3 SU 583755 A3 SU583755 A3 SU 583755A3 SU 7502145931 A SU7502145931 A SU 7502145931A SU 2145931 A SU2145931 A SU 2145931A SU 583755 A3 SU583755 A3 SU 583755A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- salts
- ring compounds
- heterogeneous ring
- hydroxy
- preparing heterogeneous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/10—Radicals substituted by singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
(54) СПСХЗОБ ПОЛУЧЕНИЯ ГЕТЕРОЦИКЛИЧЕСКИХ СОЕДИНЕНИЙ(54) AALSOB FOR GETTING HETEROCYCLIC COMPOUNDS
ИЛИ ИХ СОЛЕЙ Целевые продукты выдел ют в виде о ;но вани или перевод т их в сопи Процесс провод т преимущественно в органическом растворителе, ииертном при успо Вййх реакции, например в таком цикпичес:ком эфире или эфире с открытой цепочкой, как диоксан или диметиловый эфир диэтипенг)1И коп . В соответствующих случа х в каче :тве растворител примен ют в избытке соединени общей формулы III „ Шйймодействие можно также проводить в расплаве. Соединени обшей формулы I могут быть выделены из реакционной смеси и очтцеда, Исходные соединени общей формулы IJ известны или могут быть, получены по известным способам, исход из соответствующего оксииндола или оксифлуорен-9-оца. Соединени общей формулы HI известны. Пример I, 4-Г2-Окси-3-.{2|2,5/5«Тбтраметил-1-пирролидинил )-пропокси -&ч-фщ оренон , 4 г (2,3-9поксипропоксй)-9-.флуорен1 на нагревают с 4 г 2,2,585-тетраметиапирролидина в ЗО мл дноксана в автоклаве в течение 15 час до 1SO°C, После охлаждени реакционную смесь упариваютл остаток перенос т в эфир к экстрагируют 2 н«сол но кислотой. Водный раствор довод т до щелочной реакции и исчерпываквде экстрагируют метиленхлоридом. Метиленхпоридную фазу уп ргтвают и остаток кристаппизуют из смеси этйповь й эфир уксусной кислоты « петролей ный эфир„ Температура плавлени цепевого продукта 137-138°С. Пример 2. .( l Aaиpидинил) oкcипpoпoкcи -9-фпyopeнoн. 4г 4-(2,3-эпоксипропокси)-9-фпуоренона выдерживают в течение ночи с 15 мй этиленимила при комнатной температуре. Затем отгон ют избыточный этипенимин, остаток экстрагируют эфиром и раствор упаривают до начала кристаллизации. Температура плаёле ки целевого продукта 113-116 С, Пример 3, 4-Г2-Окси-3-{ ,2-дигидро-2-имино-1-пиримидинил )-пропокси5-9|-флуоренон . 5г 4-(2,3-эпоксипропокси)-9-флуоренона и 3, 8 г 2-аминопиримидина нагревают 30 мин до 10О°С, Расплав раствор ют в уксусном эфире и экстрагируют 2 н.сол ной кислотой . Выпавший в виде смолы гидрохлорид довод т до щелочной реакции и экстрагируют метиленхлоридом. Затем растворитель упаривают и остаток кристаллизуют из этанола (т. пл, 178-179°С). Аналогично,исход У1асоогвегствутощих исходных соединений обшей формулы II ,где X и У вместе означают -О- или X - оксигруппа и У - хлор, и общей формулы Щ, получают соединени общей формулы I , приведенные в таблице.OR THEIR SALTS The target products are isolated as o, but they are transferred or copulated. The process is carried out predominantly in an organic solvent inert at the time of the reaction, for example, in such cyclic ether or open-chain ether, like dioxane or dimethyl ether diethyping) 1I cop. In appropriate cases, as a solvent, a solvent is used in an excess of a compound of the general formula III. The reaction can also be carried out in a melt. Compounds of general formula I can be isolated from the reaction mixture and procedure. The starting compounds of general formula IJ are known or can be obtained by known methods, starting from the corresponding oxyindole or oxyfluorene-9-oct. Compounds of general formula HI are known. Example I, 4-G2-Oxy-3 -. {2 | 2.5 / 5 "Tbtramethyl-1-pyrrolidinyl) -propoxy - 4 h (2.3-9-proxy-propoxy) -9-. fluorene1 is heated from 4 g of 2,2,585-tetramethyapyrrolidine in 30 ml of donoxane in an autoclave for 15 hours to 1SO ° C. After cooling, the reaction mixture is evaporated and the residue is taken up in ether and extracted with 2N hydrochloric acid. The aqueous solution is brought to alkaline and exhaustively extracted with methylene chloride. The methylenechiporide phase is depressed and the residue is cristapized from a mixture of ethyl acetate acetic acid and petroleum ether. The melting point of the chain product is 137-138 ° C. Example 2.. (L Aairidinyl) -X-9-fpioponon. 4 g of 4- (2,3-epoxypropoxy) -9-fpuorenone is incubated overnight with 15 ml of ethylenimyl at room temperature. Excess etipenimine is then distilled off, the residue is extracted with ether and the solution is evaporated until crystallization begins. The flame temperature of the target product is 113-116 C, Example 3, 4-G2-Oxy-3- {, 2-dihydro-2-imino-1-pyrimidinyl) -propoxy5-9 | -fluorenone. 5 g of 4- (2,3-epoxypropoxy) -9-fluorenone and 3, 8 g of 2-aminopyrimidine are heated for 30 minutes to 10 ° C, the melt is dissolved in ethyl acetate and extracted with 2N hydrochloric acid. The hydrochloride precipitated out as a gum is made alkaline and extracted with methylene chloride. Then the solvent is evaporated and the residue is crystallized from ethanol (m.p., 178-179 ° C). Similarly, the outcome of the starting compounds of formula II, where X and Y together mean -O- or X-hydroxy group and Y-chloro, and the general formula U, give compounds of general formula I listed in the table.
9 Флуоренон49 Fluorenone4
То Kie4Thats kie4
1 1eleven
СWITH
™ -2™ -2
«.".
2-Индолинон42-Indolinon4
То же4Same4
9-Флуоренон49-fluorenone4
2 22 2
То же4Same4
4four
,2,6„6-Тетраметиппиперидино, 2,6 „6-Tetrametipiperidino
8-Норпропанил8-Norpropanil
2,2,5,5-Тетраметил-1 -пирролидинил2,2,5,5-Tetramethyl-1 -pyrrolidinyl
2,2,б5в-Тетраметил 2.2, b5v-tetramethyl
пиперидинеpiperidine
2,2,5,5-Тетраметил-1пирролидинил2,2,5,5-Tetramethyl-1pyrrolidinyl
9-АзабицикпоГ2,3,1 нон 9-ил.9-Azabicycpo2,3,1 non 9-yl.
1-Пирролидинип1-Pyrrolidinip
2,6-Диметилп1гаерицине2,6-dimethylphericin
9-Азабицикло 3,3, 9 -ил9-Azabicyclo 3,3, 9-yl
9 - Фпуоренон 49 - Fpuorenon 4
1313
То жеAlso
1414
1515
12-Индопинон412-Indopinon4
16 2116 21
3То же4 т. пп. гидрохпорида. Пример 22. 4-С2-Гидрокси-3-(2, 2,5,5-тетраметип-1-пирропидинип)-пропоксиЗ 9-фпуоренон. Это соединение получают анапогично примеру I, но вместо 4-(2,3-эпoкcипpoпoкcи)9-флyopeнoнa используют 4-( 3-бром-2-гидроксипропокси )-9-фпуоренон. Температура плавпени целевого продукта 137-139 0, П ри мер 23, 4- 2-Гидрокси-3-(2,2, 5,5-тетра летил-1-пирролипинил)-пропокси 9-фгЕу оренон. Это соединение получают по примеру Г, исход (2-гидрокси-З-тозилоксипропокси )-флуорен-9-она вместо 4-{2,3-эпоксипропокси )-9-фпуоренона. Температура плавпени полученного соединени 137-139°С.: Пример 24. 4- 2-Гидрокси-3-{2,2, 6,6-тетраметиппиперидино)-пропокси -2-индолинон . Аналогично примеру I, исход из 4-(2гидрокси-3-тозилоксипропокси )-2-индолинонр вместо 4-(2,3-эпоксипропокси)-9-флуоренона , получают с применением Соответствующего амин общей формуnfci Ш выше указанное соединение, т. пл. его 177-178°С. Пример 25. 4- 2-Гидрокси-3-(2,2, 6,6-тетраметилпиперидино)-пропокси -2-индолиноН . Аналогично примеру I, исход из 4(2гидрокси-3-мезипоксипропокси )-2-индопинона вместо 4(2 3-эпоксипропокси)-9-флуоре нона, получают с примене тием соответствующего амина общей формупь) Ш выше; указанное соединение, т. пп. его 177-178 0.3Top4 m. hydrochloride. Example 22. 4-C2-Hydroxy-3- (2, 2,5,5-tetrametip-1-pyrrolidinip) -propoxy 3 -fpuorenone. This compound is obtained anapogically as Example I, but instead of 4- (2,3-epoxy-propoxy) 9-fluoro- onon, 4- (3-bromo-2-hydroxypropoxy) -9-fpuorenone is used. The melting point of the desired product is 137-139 0, Example 23, 4- 2-Hydroxy-3- (2,2, 5,5-tetra letyl-1-pyrrolipinyl) -propoxy 9-fgEy oronone. This compound is prepared according to Example G, the outcome (2-hydroxy-3-tosyloxypropoxy) -fluorene-9-one instead of 4- {2,3-epoxypropoxy) -9-fpuorenone. The melting point of the obtained compound is 137-139 ° C.: Example 24. 4- 2-Hydroxy-3- {2,2, 6,6-tetrametypiperidino) -propoxy -2-indolinone. Analogously to example I, starting from 4- (2-hydroxy-3-tosyloxypropoxy) -2-indolinone instead of 4- (2,3-epoxypropoxy) -9-fluorenone, is obtained using the corresponding amine of the general form nfci III above compound, so pl. its 177-178 ° C. Example 25. 4- 2-Hydroxy-3- (2,2, 6,6-tetramethylpiperidino) -propoxy -2-indolinoH. Analogously to Example I, starting from 4 (2-hydroxy-3-mezipoxypropoxy) -2-indopinone instead of 4 (2 3-epoxypropoxy) -9-fluorenone, is obtained using the corresponding amine total form) above; the specified connection, so the PP. its 177-178 0.
Гропонжеиие табпицыGroponzheii tabpitsy
1,2-Л гилро-2-имино-.1-пир ИДИ1,2-L gilro-2-imino-.1-feast IDN
2,2,5,5-Тетраметнп-1-пирропидинил2,2,5,5-Tetrametnp-1-pyrropidinyl
АзабициклолЗ, 3, l HOIS2-ен-9--илAzabicyclols, 3, l HOIS2-en-9 - il
То жеAlso
1,2 Дигицро-2-имино- 1-пириднп ормула изобретени Способ получени гетероциклических ннений обшей формулы } ОН Het- О -CHj- СН , Het - остаток 2 индолинона, который ан с боковой цепочкой в положении 4 т нового кольца, или остаток Э флуоренов заннь й с боковой цепочкой в положе1 ,2 или 4 фпуоренонового кольца; R, - радикал: /PI х ДСНгУ -О 1 ЛГ7 -д 2V в . Rj - водород или метил; А - В - этилен или виниден; п 2 или 3; п 1 или 2, ли их солей, о т л и ч а ю ш и и с что соепинеппе обшей jT Het - О -СН.,-СИ X У I Het имеет указантп:1е BFjUiie значени ; оксигруппа; У - галоген или группа . - О-, hae Кд - фенил, тол п ипи низшей алкип, ил X и У вместе обозначают -0-, подвергают взаимодействию при темпера туре от комнатной до 2ОО°С с соеднненнем общей формулы Ш R-H, где R вмеет указашше вьпое значекп , с (юспвоующнм выделением целевого продукта в виде оснсаан или в виае соли. Приоритет ио признакам: 19.ОвЛ4 нри Het - остаток 9-ф уоре ов« , который св зан с боксеой цепочкой в положени 1,2 или 4 ({луорешэиьдого кольца К - радикал; А «г% где RJ - водороп, или метил; Л - В этипеи или Биннпен; . 2 или 3; п« 1 или 2. 19.06.74 при Het - остаток 2-индолинона , который св зан с боковой цепочкой в положении 4 инаолинового кольца; lit - радикал -/ Л -т Rf И где HI - водород или метил; А-В - этилец п в 2 или 3; 1 ИПЯ 2. Источники информации, прин тые во внимание при экспертизе: 1. Вейганд-Хильгетаг Методы эксперимента b органической химии, М., Хими , 1988, с. 415.1.2 Digitsro-2-imino-1-pyridine formula of the invention. Method of obtaining heterocyclic formulations of the general formula} HE Het-O-CHj-CH, Het - residue 2 of indolinone, which is with a side chain in the 4 t position of a new ring, or residue E fluorene zannyy with a side chain in position 1, 2 or 4 fuporenon ring; R, is a radical: / PI x DSNgU -O 1 LG7-d 2V c. Rj is hydrogen or methyl; A - B - ethylene or vinide; n 2 or 3; p 1 or 2, whether their salts, of which it is soepeniepé common jT Het - O —CH., - SI X Y I Het has a directive: 1e BFjUiie value; hydroxy group; Y - halogen or group. - O-, hae Kd - phenyl, weight of lower alkyl, silt X and Y together designate -0-, are subjected to interaction at a temperature from room temperature to 2OO ° С with the compound of the general formula III RH, where R has the indicated sign, with (by extracting the target product in the form of ossaaan or in salt). Priority to signs: 19.OVL4 at Het is the remainder of 9-f oorov, which is associated with the boxed chain in the position of 1,2 or 4 ({ is a radical; A "g% where RJ is hydrogenated or methyl; L is B etipei or Binnpen; 2 or 3; n" 1 or 2. 06/19/74 with Het is the residue of 2-indolinone, which is n with a side chain in position 4 of the inaolin ring; lit is the radical - / L –t Rf And where HI is hydrogen or methyl; AB — ethylene n in 2 or 3; 1 IRN 2. Sources of information taken into account Expertise: 1. Weigand-Hilgetag Experimental Methods b Organic Chemistry, M., Himi, 1988, pp. 415.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH838174A CH602710A5 (en) | 1974-06-19 | 1974-06-19 | Substd. 9-fluorenone and 2-indolinone derivs |
CH838074A CH599160A5 (en) | 1974-06-19 | 1974-06-19 | Substd. 9-fluorenone and 2-indolinone derivs |
Publications (1)
Publication Number | Publication Date |
---|---|
SU583755A3 true SU583755A3 (en) | 1977-12-05 |
Family
ID=25703229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU7502145931A SU583755A3 (en) | 1974-06-19 | 1975-06-19 | Method of preparing heterogeneous ring compounds or salts thereof |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS51125060A (en) |
AT (1) | ATA466375A (en) |
AU (1) | AU8216875A (en) |
CA (1) | CA1036163A (en) |
DD (1) | DD118086A5 (en) |
DE (1) | DE2525656A1 (en) |
DK (1) | DK259475A (en) |
ES (1) | ES438637A1 (en) |
FI (1) | FI751727A (en) |
FR (1) | FR2275200A1 (en) |
GB (1) | GB1500063A (en) |
HU (1) | HU169926B (en) |
IE (1) | IE41562B1 (en) |
IL (1) | IL47503A0 (en) |
NL (1) | NL7507131A (en) |
NO (1) | NO752078L (en) |
SE (1) | SE7506757L (en) |
SU (1) | SU583755A3 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0005828B1 (en) * | 1978-06-06 | 1981-03-11 | Hoechst Aktiengesellschaft | New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation |
AU773538B2 (en) | 1999-01-22 | 2004-05-27 | Elan Pharmaceuticals, Inc. | Acyl derivatives which treat VLA-4 related disorders |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
ATE502031T1 (en) | 2005-09-29 | 2011-04-15 | Elan Pharm Inc | CARBAMAT COMPOUNDS THAT INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 |
JP5101512B2 (en) | 2005-09-29 | 2012-12-19 | エラン ファーマシューティカルズ,インコーポレイテッド | Pyrimidinylamide compounds that inhibit leukocyte adhesion mediated by VLA-4 |
NZ570679A (en) | 2006-02-27 | 2011-01-28 | Elan Pharm Inc | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated By VLA-4 |
SG175355A1 (en) | 2009-04-27 | 2011-12-29 | Elan Pharm Inc | Pyridinone antagonists of alpha-4 integrins |
-
1975
- 1975-06-09 DE DE19752525656 patent/DE2525656A1/en active Pending
- 1975-06-10 FI FI751727A patent/FI751727A/fi unknown
- 1975-06-10 DK DK259475A patent/DK259475A/en unknown
- 1975-06-11 NO NO752078A patent/NO752078L/no unknown
- 1975-06-12 SE SE7506757A patent/SE7506757L/en unknown
- 1975-06-16 GB GB25530/75A patent/GB1500063A/en not_active Expired
- 1975-06-16 NL NL7507131A patent/NL7507131A/en not_active Application Discontinuation
- 1975-06-17 FR FR7518882A patent/FR2275200A1/en active Granted
- 1975-06-17 ES ES438637A patent/ES438637A1/en not_active Expired
- 1975-06-17 AU AU82168/75A patent/AU8216875A/en not_active Expired
- 1975-06-17 IL IL47503A patent/IL47503A0/en unknown
- 1975-06-17 DD DD186699A patent/DD118086A5/xx unknown
- 1975-06-17 HU HUSA2805A patent/HU169926B/hu unknown
- 1975-06-17 IE IE1359/75A patent/IE41562B1/en unknown
- 1975-06-18 CA CA229,607A patent/CA1036163A/en not_active Expired
- 1975-06-18 AT AT466375A patent/ATA466375A/en not_active Application Discontinuation
- 1975-06-18 JP JP50073280A patent/JPS51125060A/en active Pending
- 1975-06-19 SU SU7502145931A patent/SU583755A3/en active
Also Published As
Publication number | Publication date |
---|---|
SE7506757L (en) | 1975-12-22 |
FR2275200B1 (en) | 1979-06-08 |
IE41562L (en) | 1975-12-19 |
HU169926B (en) | 1977-02-28 |
IE41562B1 (en) | 1980-01-30 |
DD118086A5 (en) | 1976-02-12 |
CA1036163A (en) | 1978-08-08 |
NO752078L (en) | 1975-12-22 |
ES438637A1 (en) | 1977-06-01 |
FI751727A (en) | 1975-12-20 |
NL7507131A (en) | 1975-12-23 |
AU8216875A (en) | 1976-12-23 |
DK259475A (en) | 1975-12-20 |
ATA466375A (en) | 1979-08-15 |
DE2525656A1 (en) | 1976-01-15 |
GB1500063A (en) | 1978-02-08 |
IL47503A0 (en) | 1975-08-31 |
JPS51125060A (en) | 1976-11-01 |
FR2275200A1 (en) | 1976-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3853915A (en) | 9-or 10-halo-4h-benzo{8 4,5{9 cyclo-hepta{8 1,2-b{9 thiophen-4-ones | |
US3912741A (en) | 1-(Benzo{8 b{9 thienylalkyl)piperidines | |
NO119274B (en) | ||
SU583755A3 (en) | Method of preparing heterogeneous ring compounds or salts thereof | |
NO820937L (en) | 9- (2- (3-INDOLYL) ETHYL) -1-OKSA-4,9-DIAZASPIRO (5,5) -DECAN-3-ONES AND PROCEDURES FOR THEIR PREPARATION | |
US3705907A (en) | 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives | |
CZ285369B6 (en) | Derivative of 3-indolylpiperidine, process of its preparation, its use for preparing a medicament and pharmaceutical composition containing thereof | |
NO821616L (en) | 1-SUBSTITUTED SPIRO (PIPERIDIN-OXOBENZOCSAZIN) IS AND PROCEDURE FOR THEIR PREPARATION | |
NO142173B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITIES, 1,1-DIARYL-1-OXADADZOLALKYLAMINE DERIVATIVES | |
NO803453L (en) | PROCEDURE FOR THE PREPARATION OF PIPERIDYLBENZIMIDAZOLONE DERIVATIVES | |
NO760774L (en) | ||
US3696120A (en) | 4-(2-hydroxy-3-amino propoxy)-indole derivatives | |
NO163597B (en) | CONTROL DEVICE FOR A ONE OR TWO TRACKED VEHICLE. | |
US2694705A (en) | Nx c c ox a a | |
NO124724B (en) | ||
NO164899B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLYLINDOL COMPOUNDS. | |
NO151387B (en) | SETTING DEVICE FOR AN ELECTRONIC DIGITAL INDICATOR | |
NO122926B (en) | ||
SU694071A3 (en) | Method of preparing piperazine derivatives or their acidic additive salts or quaternary salts | |
DK155938B (en) | ANALOGY PROCEDURE FOR PREPARING BENZISOXAZOLD DERIVATIVES | |
US2951080A (en) | Novel phenyl-substituted piperidines | |
US3549641A (en) | Pyrano pyridines and process for their production | |
US3391143A (en) | 9-piperidyl and 9-piperidylidene derivatives of acridan | |
US3305560A (en) | 3-phthalidyl-2-indolinones | |
NO131172B (en) |